Company intelligence / Profile preview

JM Biotech

Seoul, Seoul, South Koreajmbiotech.co.kr ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

JMBIOTECH Corporation Limited (“JM Biotech”) is an active biotechnological company headquartered in Seoul specializing in innovative healthcare solutions including medical devices like TurtlePin®, cosmeticeuitcals for aesthetic medicine professionals & consumers worldwide. It operates commercially across over three dozen countries under its parent Jeilmedix Pharmaceutical.

Therapeutic areas: OtherDermatology
Modalities: DeviceCosmeceutical productNutraceutical supplement
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

TurtlePin HL

Commercial

Indications: Hair loss

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on JM Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JM Biotech.

Explore the full profile